Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO PracticeUpdate Conference Series:

Videos from #ESMO20 on Melanoma

Key Takeaways from ESMO: updates on immunotherapy for melanoma

Roxana Dronca

  1. There was some key data on immunotherapy for metastatic melanoma presented at this year's ESMO. Could you describe some of the most relevant findings?
  2. Was this complete response predictive of long-term outcomes? - How would this impact clinical practice?
  3. Was there any data presented at ESMO that might help address the needs of these relatively less responsive patients?
  4. What other combinations were presented at ESMO this year?
Key Takeaways from ESMO: Updates in Targeted Therapy for Melanoma

Alexander CJ van Akkooi

  1. What are the most exciting updates in targeted therapy for metastatic melanoma from this conference?
  2. Did we learn anything new about adjuvant treatment from these presentations?
  3. Finally, are there any novel targeted therapies that we should keep our eyes on?

The ESMO PU Conference Series – A collaboration brought to you by Elsevier’s PracticeUpdate and the European Society for Medical Oncology.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings